Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Horikawa

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
American Journal of Clinical Oncology|September 21, 2017
Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric CancerAyumu Hosokawa, Takayuki Ando, Kohei Ogawa, et al.
International Journal of Clinical Oncology|January 15, 2025
Re-evaluating prognostic factors for cervical cancer with lymph node metastasis: a Japanese multicenter cohort study based on FIGO 2018Kohei Hamada, Koji Yamanoi, Nobutaka Hayashi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 19, 2012
Efficacy of weekly paclitaxel in patients with advanced gastric cancer refractory to docetaxel-based chemotherapyTakayuki Ando, Ayumu Hosokawa, Shinya Kajiura, et al.
Nature Communications|April 29, 2018
Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulationMana Taki, Kaoru Abiko, Tsukasa Baba, et al.
Journal of Gynecologic Oncology|January 23, 2026
Possible overestimation of treatment effects of pelvic and para-aortic lymphadenectomy for early-stage ovarian clear cell carcinoma: a retrospective propensity-score weighted multi-center cohort studyNaoki Horikawa, Yoshihide Inayama, Miki Otsuki, et al.
The Journal of International Medical Research|February 3, 2016
Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancerHisham A Abou-Taleb, Masafumi Koshiyama, Noriomi Matsumura, et al.
In Vivo (Athens, Greece)|January 6, 2021
Prognosis of Immune-related Adverse Events in Patients With Advanced Gastric Cancer Treated With Nivolumab or Pembrolizumab: A Multicenter Retrospective AnalysisTakayuki Ando, Akira Ueda, Kohei Ogawa, et al.
Gastroenterology Research and Practice|April 5, 2012
Irinotecan plus mitomycin C as second-line chemotherapy for advanced gastric cancer resistant to fluoropyrimidine and Cisplatin: a retrospective studyKohei Ogawa, Ayumu Hosokawa, Akira Ueda, et al.
Frontiers in Psychiatry|June 16, 2025
Higher clozapine concentration-to-dose ratios at week 1 after initiation are associated with increased risk of clozapine-associated fever in Japanese patients with schizophreniaYuki Kikuchi, Hiroaki Tanifuji, Mutsumi Sakata, et al.
Anticancer Research|November 14, 2013
Non-randomized comparison between irinotecan plus mitomycin C and irinotecan alone in patients with advanced gastric cancer refractory to fluoropyrimidine and platinumAkira Ueda, Ayumu Hosokawa, Kohei Ogawa, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
American Journal of Clinical Oncology|September 21, 2017
Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric CancerAyumu Hosokawa, Takayuki Ando, Kohei Ogawa, et al.
International Journal of Clinical Oncology|January 15, 2025
Re-evaluating prognostic factors for cervical cancer with lymph node metastasis: a Japanese multicenter cohort study based on FIGO 2018Kohei Hamada, Koji Yamanoi, Nobutaka Hayashi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 19, 2012
Efficacy of weekly paclitaxel in patients with advanced gastric cancer refractory to docetaxel-based chemotherapyTakayuki Ando, Ayumu Hosokawa, Shinya Kajiura, et al.
Nature Communications|April 29, 2018
Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulationMana Taki, Kaoru Abiko, Tsukasa Baba, et al.
Journal of Gynecologic Oncology|January 23, 2026
Possible overestimation of treatment effects of pelvic and para-aortic lymphadenectomy for early-stage ovarian clear cell carcinoma: a retrospective propensity-score weighted multi-center cohort studyNaoki Horikawa, Yoshihide Inayama, Miki Otsuki, et al.
The Journal of International Medical Research|February 3, 2016
Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancerHisham A Abou-Taleb, Masafumi Koshiyama, Noriomi Matsumura, et al.
In Vivo (Athens, Greece)|January 6, 2021
Prognosis of Immune-related Adverse Events in Patients With Advanced Gastric Cancer Treated With Nivolumab or Pembrolizumab: A Multicenter Retrospective AnalysisTakayuki Ando, Akira Ueda, Kohei Ogawa, et al.
Gastroenterology Research and Practice|April 5, 2012
Irinotecan plus mitomycin C as second-line chemotherapy for advanced gastric cancer resistant to fluoropyrimidine and Cisplatin: a retrospective studyKohei Ogawa, Ayumu Hosokawa, Akira Ueda, et al.
Frontiers in Psychiatry|June 16, 2025
Higher clozapine concentration-to-dose ratios at week 1 after initiation are associated with increased risk of clozapine-associated fever in Japanese patients with schizophreniaYuki Kikuchi, Hiroaki Tanifuji, Mutsumi Sakata, et al.
Anticancer Research|November 14, 2013
Non-randomized comparison between irinotecan plus mitomycin C and irinotecan alone in patients with advanced gastric cancer refractory to fluoropyrimidine and platinumAkira Ueda, Ayumu Hosokawa, Kohei Ogawa, et al.
Pageof 6